Foguth Wealth Management LLC. Grows Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Foguth Wealth Management LLC. lifted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 27.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 521 shares of the healthcare conglomerate’s stock after acquiring an additional 113 shares during the quarter. Foguth Wealth Management LLC.’s holdings in UnitedHealth Group were worth $277,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Clayton Financial Group LLC increased its holdings in UnitedHealth Group by 80.0% during the fourth quarter. Clayton Financial Group LLC now owns 3,970 shares of the healthcare conglomerate’s stock valued at $2,009,000 after buying an additional 1,765 shares during the period. Choreo LLC raised its position in shares of UnitedHealth Group by 8.7% in the 4th quarter. Choreo LLC now owns 39,204 shares of the healthcare conglomerate’s stock worth $19,882,000 after acquiring an additional 3,132 shares in the last quarter. Nvwm LLC raised its holdings in UnitedHealth Group by 0.9% in the fourth quarter. Nvwm LLC now owns 4,101 shares of the healthcare conglomerate’s stock worth $2,075,000 after purchasing an additional 36 shares in the last quarter. Money Concepts Capital Corp grew its position in shares of UnitedHealth Group by 1.4% in the 4th quarter. Money Concepts Capital Corp now owns 3,800 shares of the healthcare conglomerate’s stock worth $1,922,000 after buying an additional 54 shares during the last quarter. Finally, Confluence Wealth Services Inc. boosted its stake in UnitedHealth Group by 13.0% in the fourth quarter. Confluence Wealth Services Inc. now owns 6,868 shares of the healthcare conglomerate’s stock valued at $3,638,000 after acquiring an additional 789 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Activity

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The shares were bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Company insiders own 0.33% of the company’s stock.

Analyst Upgrades and Downgrades

UNH has been the topic of several research analyst reports. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. KeyCorp reaffirmed an “overweight” rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Deutsche Bank Aktiengesellschaft raised their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Barclays reduced their target price on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday, January 17th. Finally, Piper Sandler reduced their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. One research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $539.50 on Thursday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $496.49 billion, a P/E ratio of 34.81, a P/E/G ratio of 1.48 and a beta of 0.61. The business’s 50 day moving average is $533.81 and its two-hundred day moving average is $564.94. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same period last year, the firm posted $5.83 earnings per share. The company’s revenue was up 6.8% compared to the same quarter last year. Analysts expect that UnitedHealth Group Incorporated will post 29.63 EPS for the current fiscal year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.